Subcutaneous drug delivery devices—Enablers of a flexible care setting-Reference-Cited by-同舟云学术

Subcutaneous drug delivery devices—Enablers of a flexible care setting

Published:2021 Issue: Volume: Page:159-179
ISSN:
Container-title:Drug Delivery Devices and Therapeutic Systems
language:
Short-container-title:

Author:

Bittner Beate,Schmidt Johannes

Publisher

Elsevier

Reference97 articles.

1. Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting;Bittner;Med. Devices (Auckl.),2019

2. Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities;Bittner;BioDrugs,2018

3. Home versus hospital immunoglobulin treatment for autoimmune neuropathies: a cost minimization analysis;Le Masson;Brain Behav.,2018

4. Improving adherence to injectable disease-modifying drugs in multiple sclerosis;Bayas;Expert Opin. Drug Deliv.,2013

5. Patient satisfaction with the new interferon beta-1b autoinjector (BETACONNECT™);Ziemssen;Neurol. Ther.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects;Pharmaceutical Research;2024-03-05

2. Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access;BioDrugs;2023-10-13

3. Drug delivery breakthrough technologies – A perspective on clinical and societal impact;Journal of Controlled Release;2023-08

4. Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework;Expert Opinion on Drug Delivery;2023-02-28

5. Customer-centric product presentations for monoclonal antibodies;AAPS Open;2023-01-23